PFE Pfizer PE ratio, current and historical analysis
As of Apr 1, 2025, the PFE stock has a PE ratio of 17.28. The calculation is based on the latest EPS of $1.42 and the stock price of $24.54 per share.
PFE PE ratio history
The mean historical PE ratio of Pfizer over the last ten years is 19.97. The current 17.28 P/E ratio is 13% lower than the historical average. Looking back at the last ten years, PFE's PE ratio peaked in the Dec 2023 quarter at 75.76, with a price of $28.79 and an EPS of $0.38. The Apr 2023 quarter marked the lowest point at 7.89, with a price of $40.8 and an EPS of $5.17.
Pfizer PE ratio by year
Maximum annual increase: 726.17% in 2023
Maximum annual decrease: -75.34% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 18.68 | -75.34% | $26.53 | $1.42 |
| 2023 | 75.76 | 726.17% | $28.79 | $0.38 |
| 2022 | 9.17 | -39.11% | $51.24 | $5.59 |
| 2021 | 15.06 | -32.5% | $59.05 | $3.92 |
| 2020 | 22.31 | 64.04% | $36.81 | $1.65 |
| 2019 | 13.6 | -40.79% | $39.18 | $2.88 |
| 2018 | 22.97 | 126.31% | $43.65 | $1.9 |
| 2017 | 10.15 | -63.13% | $36.22 | $3.57 |
| 2016 | 27.53 | -3.64% | $32.48 | $1.18 |
| 2015 | 28.57 | 32.09% | $32.28 | $1.13 |
| 2014 | 21.63 | 128.16% | $31.15 | $1.44 |
| 2013 | 9.48 | -25.94% | $30.63 | $3.23 |
| 2012 | 12.8 | -24.31% | $25.08 | $1.96 |
| 2011 | 16.91 | -0.53% | $21.64 | $1.28 |
| 2010 | 17 | 14.94% | $17.51 | $1.03 |
Pfizer PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 18.68 | -51.2% | $26.53 | $1.42 |
| Sep 2024 | 38.28 | N/A | $29.09 | $0.76 |
| Jun 2024 | N/A | N/A | $27.98 | -$0.45 |
| Mar 2024 | N/A | N/A | $27.75 | -$0.05 |
| Dec 2023 | 75.76 | 322.53% | $28.79 | $0.38 |
| Oct 2023 | 17.93 | 86.19% | $33.17 | $1.85 |
| Jul 2023 | 9.63 | 22.05% | $36.68 | $3.81 |
| Apr 2023 | 7.89 | -13.96% | $40.8 | $5.17 |
| Dec 2022 | 9.17 | 11.29% | $51.24 | $5.59 |
| Oct 2022 | 8.24 | -17.76% | $43.76 | $5.31 |
| Jul 2022 | 10.02 | -13.7% | $52.31 | $5.22 |
| Apr 2022 | 11.61 | -22.91% | $51.57 | $4.44 |
| Dec 2021 | 15.06 | 21.35% | $59.05 | $3.92 |
| Oct 2021 | 12.41 | -29.09% | $42.93 | $3.46 |
| Jul 2021 | 17.5 | -7.94% | $39.73 | $2.27 |
PFE average PE ratio chart
PFE's current PE ratio is lower than its 3, 5 and 10-year averages.
PFE PE vs peers
PFE's PE ratio stands lower than its peer stocks LLY and JNJ, but it is higher than ABT's and MRK's. Pfizer is currently trading at a lower PE ratio (17.28) than its peers average of 30.79.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 12.89 | $220.07B |
| ABT Abbott Laboratories | 17.17 | $228.39B |
| PFE Pfizer Inc | 17.28 | $139.08B |
| NVS Novartis AG | 18.52 | $216.49B |
| JNJ Johnson & Johnson | 26.24 | $368.97B |
| AZN Astrazeneca plc | 31.98 | $225.14B |
| AMGN Amgen Inc | 40.28 | $164.88B |
| LLY ELI LILLY & Co | 68.47 | $763.49B |
| BMY Bristol Myers Squibb Co | N/A | $120.85B |
Frequently asked questions
What is Pfizer's PE ratio?
As of Apr 1, 2025, PFE stock has a price to earnings ratio of 17.28.
What is the 3-year average PE ratio for Pfizer (PFE)?
The average PE ratio for PFE stock over the past 3 years is 20.72.
What is the 5-year average PE ratio for Pfizer (PFE)?
The average PE ratio for PFE stock over the past 5 years is 19.54.
What is the highest PE ratio for PFE?
Over the last ten years, the quarterly PE ratio reached its highest level at 75.76 in the Dec 2023 quarter.
How does the current PE ratio for PFE compare to its historical average?
PFE's current price to earnings ratio is 13% below its 10-year historical average.
How is PFE's PE ratio calculated (Pfizer PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 1, 2025), Pfizer's share price is $24.54. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.42. Therefore, Pfizer's PE ratio for today is 17.28. PE RATIO(17.28) = STOCK PRICE($24.54) / TTM EPS($1.42)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.